Wednesday, December 11, 2019


Organigram Hlds Inc
(NASDAQ: OGI) Add to Watchlist
-0.02 (-0.78%)
as of Dec 11, 2019

Last 2.56
Change -0.02 (-0.78%)
Open 2.59
Prev. Close 2.58
Today's Range
2.54 2.62
52wk Range
2.00 8.44
Volume 1,503,046
Avg Volume 3,640,847
Sector SIC-2834 Pharmaceutical Preparations

Recent Headlines
The global Cannabis Market size is projected to reach USD 97.35 billion by the end of 2026. According to a report published by Fortune Business Insights(TM), titled "Cannabis Market Size, Share and Industry Analysis by Type (Flowers/Buds and Concentrates), By Application (Medical, Recreational (Edib  (full story)
MEDFF: 18.8100 (-0.0700), OGI: 2.56 (-0.02)
There's no hiding the fact that the legal recreational pot industry has underperformed. Challenges primarily at the retail level--such as a lack of dispensaries, unnecessarily burdensome regulations, and a rapid erosion of investor trust--have led the pot space to fall short of reaching its full pot  (full story)
OGI.TO: 3.36 (-0.06), OGI: 2.56 (-0.02), FAF.TO: 0.81 (-0.01), FFLWF: 0.6022 (-0.0128), FIRE.TO: 0.62 (-0.03), SPRWF: 0.4800 (-0.0131), APHA.TO: 6.45 (-0.10)
For the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a "breakthrough therapy" for the treatment of major depressive disorder (MDD). "This designation, which is designed to expedite the development and review of drugs--given out only for therapies  (full story)
BOSS.CN: 0.235 (-0.005), BOSQF: 0.1798 (-0.0002), HEXO: 2.19 (unch), HEXO.TO: 2.86 (-0.02), TRUL.CN: 15.710 (-0.790), TCNNF: 11.9000 (-0.5500), TGOD.TO: 0.76 (-0.02)
Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX: OGI) (NASDAQ: OGI) announced today that it has established an at-the-market equity program (the "ATM Program") that allows the Corporation to issue up to C$55,000,000 (or its U.S. dollar equivalent) of common shares ("Common Shares")  (full story)
OGI.TO: 3.36 (-0.06), OGI: 2.56 (-0.02)
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce its results for the fourth quarter and fiscal year ended August 31, 2019 ("Q4" or "Q4 2019").  (full story)
OGI: 2.56 (-0.02), OGI.TO: 3.36 (-0.06)
Performance Comparison
Name Today 3-Month 1-Year
OGI -0.78% -27.68% -31.18%
DJIA +0.11% +5.04% +14.53%
S&P 500 +0.29% +6.85% +19.15%

Key Statistics
Annual EPS -0.04
Dividend & Yield 0.00 (0.00%)
P/E Ratio N/A
Market Capitalization, $K 420,120
Weighted Alpha -39.03
Standard Deviation -0.11
Profit Margin --
Beta N/A

Growth Rates
YTD -28.25%
1-Year -30.08%
3-Year +9.12%
5-Year +319.99%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.